ABC of mental health: SchizophreniaBMJ 1997; 315 doi: https://doi.org/10.1136/bmj.315.7100.108 (Published 12 July 1997) Cite this as: BMJ 1997;315:108
- Trevor Turner
Schizophrenia is a relatively common form of psychotic disorder (severe mental illness). Its lifetime prevalence is nearly 1%, its annual incidence is about 10-15 per 100 000, and the average general practitioner cares for 10-20 schizophrenic patients depending on the location and social surroundings of the practice. It is a syndrome with various presentations and a variable, often relapsing, long term course.
Although schizophrenia is publicly misconceived as “split personality,” the diagnosis has good reliability, even across ages and cultures, though there is no biochemical marker. Onset before the age of 30 is the norm, with men tending to present some four years younger than women. Clues as to aetiology are tantalising, and management remains endearingly clinical.
Evidence for a genetic cause grows stronger: up to 50% of identical (monozygotic) twins will share a diagnosis, compared with about 15% of non-identical (dizygotic) twins. The strength of genetic factors varies across families, but some 10% of a patient's first degree relatives (parents, siblings, and children) will also be schizophrenic, as will 50% of the children of two schizophrenic parents.
Premorbid abnormalities of speech and behaviour may be present during childhood. The role of obstetric complications and viral infection in utero remains unproved. Enlarged ventricles and abnormalities of the temporal lobes are not uncommon findings from computed tomography of the brain. Thus, a picture is emerging of a genetic brain disorder, enhanced or brought out by subtle forms of environmental damage.
Symptoms are characterised most usefully as positive or negative, although the traditional diagnostic subcategories (hebephrenic, paranoid, catatonic, and simple) have mixtures of both
Positive symptoms and signs
Clinical features suggesting diagnosis of schizophrenia
Third person auditory hallucinations
Running commentary on person's actions
Two or more voices discussing the person
Voices speaking the person's thoughts
Alien thoughts being inserted into or withdrawn from person's mind
Person's thoughts being broadcast or read by others
Person's actions being caused and controlled by some outside agency
Bodily sensations being imposed by some outside agency
Delusional perception (a delusion arising suddenly and fully formed in the wake of a normal perception)
These features, termed “symptoms of the first rank” by Schneider, suggest a diagnosis of schizophrenia. However, they are not necessary for the diagnosis, and they have neither aetiological nor prognostic importance
These are essentially disordered versions of the normal brain functions of thinking, perceiving, formation of ideas, and sense of self. Patients with thought disorder may present with complaints of poor concentration or of their mind being blocked or emptied (thought block): a patient stopping in a perplexed fashion while in mid-speech and the interviewer having difficulty in following the speech are typical signs.
Hallucinations—These are false perceptions in any of the senses: a patient experiences a seemingly real voice or smell, for example, although nothing actually occurred. The hallmark of schizophrenia is that patients experience voices talking about them as “he” or “she” (third person auditory hallucinations), but second person “command” voices also occur, as do olfactory, tactile, and visual hallucinations.
Delusions—These are false beliefs held with absolute certainty, dominating the patient's mind, and untenable in terms of the sociocultural background. Delusions often derive from attempts to make sense of other symptoms such as the experience of passivity (sensing that someone or something is controlling your body, emotions, or thoughts). Typical experiences are of thoughts being taken or sucked out of your head (a patient insisted that her mother was “stealing her brain”) or inserted into your mind or of your thoughts being known to others (respectively termed thought withdrawal, thought insertion, and thought broadcast). Cult beliefs in telepathy and mind control may relate to partial forms of these experiences.
Classification of the major psychotic disorders*
F22 Persistent delusional disorders
Characterised by delusions but without schizophrenia-like symptoms and little deterioration in personality
Includes the disorders previously termed paranoid psychosis and paraphrenia
F23 Acute and transient psychotic disorders
Mixed group of disorders with an acute onset, which may be stress related, and a brief clinical course
Includes syndromes previously called psychogenic, reactive, and schizophreniform psychoses
F25 Schizoaffective disorders
F30 Manic episode
Hypomania is a mild form without psychotic features
F31 Bipolar affective disorder
Previously termed manic-depressive psychosis
Psychotic symptoms may occur in both manic and depressive phases of illness but are not invariably present
The disorders listed above are characterised by the presence of psychotic symptoms (delusions and hallucinations). Such symptoms may occur in many mental disorders, including dementias and depression. Schizotypal disorder (F21) is also classified in this group but is regarded by many as primarily a disorder of personality
These involve loss of personal abilities such as initiative, interest in others, and the sense of enjoyment (anhedonia). Blunted or fatuous emotions (flat affect), limited speech, and much time spent doing nothing are typical behaviours.
Forms of schizophrenia
Paranoid schizophrenia, the increasingly common form, is dominated by florid, positive symptoms, especially delusions, which may build up into a complex conspiracy theory that seems initially quite credible. The term paranoid has a broader meaning than persecutory, defining a sense of things around you having special, personal significance. Thus, car lights flashing may be evidence that the IRA are following you or proof that Princess Diana is in love with you. The more bizarre the beliefs, the easier the diagnosis.
In contrast, those presenting only with negative symptoms are described as having simple schizophrenia, while hebephrenia is a mix of negative and positive symptoms with insidious onset in adolescence.
The early stages of schizophrenic illnesses can vary considerably. A typical presentation is a family's concerns that a personality has changed or an insistence that a son “must be on drugs.” A decline in personal hygiene, loss of jobs and friends for no clear reason, and depressive symptoms mixed with a degree of ill defined perplexity are all common. About one in 10 sufferers commit suicide, usually as younger patients. It is relatively rare for sufferers to assault others.
Diagnosis remains a clinical skill, requiring a good social history corroborated by others as well as a detailed assessment of the patient's mental state
Presentations evolve over time, from non-specific depression or anxiety into overt psychotic states with typical symptoms. Differential diagnosis is limited, but routine blood tests, a urine screen for drug metabolites, and special investigations are useful to exclude rarer conditions. Temporal lobe epilepsy, cerebral lesions, hypothyroidism (in older patients), and systemic lupus erythematosus are possibilities. The hallucinations associated with alcoholism, illicit drugs, and medications should also be considered.
Management requires pharmacological, psychological, and social approaches, depending on the stage of the illness.
Advantages of early recognition and treatment
Anxiety and depression
Frequency of relapse
Loss of personal self care skills
Social disruption and deterioration
Loss of family support and social networks
Loss of interpersonal skills
Early treatment with antipsychotic drugs is central to resolving unpleasant symptoms and social impairment. First line treatment requires dopamine blocking drugs such as haloperidol, chlorpromazine, trifluoperazine, sulpiride, and pimozide. Some are available only as oral preparations, and they vary in their sedating and arousing properties as well as side effects.
Continuing treatment—Depot injections giving slow, stable release of drugs over one to four weeks are extremely useful. They enhance compliance, a particular problem in those patients who lack insight. Relief of symptoms is achieved in at least 70% of patients with such treatment.
Side effects of antipsychotic drugs
Acute dystonias and dyskinesias
Neuroleptic malignant syndrome
Medium term (weeks)
Raised prolactin concentrations, leading to:
Prolonged QTc interval and dysrhythmias
Long term (months)
Side effects are a particular problem, especially those affecting movement. Parkinsonian symptoms require antimuscarinic drugs (such as procyclidine or orphenadrine) in a third or more of patients. Sedation or a sense of feeling flattened or depressed may also be distressing. Restlessness, either psychological or affecting the legs (akathisia), is poorly understood but can respond to ß blockers. Benzodiazepines usefully treat common problems such as excessive arousal or anxiety or difficulties in sleeping.
Newer “atypical” antipsychotic drugs, such as clozapine or risperidone, have an additional blocking action on serotonin receptors that seems to reduce side effects and negative symptoms. Development of such “cleaner” drugs is one of the most exciting aspects of research in managing schizophrenia.
Psychological interventions can minimise distress and reduce frequency of relapse
Psychological interventions have centred on work with individual patients to develop social skills. Relapse in schizophrenia seems closely associated with the level of the family's emotional expression as measured by formal assessments of critical comments or expressed hostility in family interviews. Identifying an overinvolved, somewhat angry, and garrulous mother is not difficult.
Psychological and social interventions
Training in personal hygiene and self care
Training in social skills
Training in budgeting and daily living
Training in job skills
Training in anxiety management
Cognitive therapy for delusions and hallucinations
With patient's family
Information and support
Education about illness and its effects
Telephone helpline for out of hours support
Self help and carers groups
Family therapy to reduce high expressed emotion
Fashionable theories of causation in the 1960s, which designated the “schizophrenogenic” parent, have now been discarded. There is, however, a close association between high arousal in the family and early relapse: this can be lowered by structured family education, reducing face-to-face contact via attendance at a day centre, and formal family therapy. Recently, cognitive therapy to reduce the impact of delusional beliefs or hallucinations has shown promise.
A key worker can help with medication, disability benefits, and housing needs. Hostels or group homes vary in structure and support, from the high dependence units that provide 24 hour care to the semi-independence of a supported flat with someone visiting daily or less often. Day care, whether an active rehabilitation unit aimed at developing job skills or simply support with low key activities, can improve personal functioning (for example hygiene, conversation, and friendships) as well as ensuring early detection of relapse.
Social interventions are the cornerstone of community care
Outcome in schizophrenia
Highly dependent Up to 20% of sufferers will require long term, highly dependent, structured care, sometimes in locked or secure conditions
Relatively independent About half of patients can live relatively independent lives, with varying levels of support, but require continuing medication
Independent The best 30% are independent, working full time, and raising families. Illness with such a good outcome is sometimes termed schizoaffective, and there is continuing debate about the relation between chronic, “process” schizophrenia and those brief psychotic episodes that leave people largely untouched
There is evidence that targeted community support may reduce the need for respite crisis or compulsory admissions. However, the myth that community care supplants the need for hospital beds is being superseded, particularly where there are high levels of homelessness, such as in the inner cities. A ratio of one acute bed for 10 community placements is probably acceptable.
Prognosis depends on presentation, response to treatment, and the quality of aftercare. Early and continued medication remains the key to good management. Acute onset over several weeks rather than many months, a supportive family, personal intelligence and insight, positive rather than negative symptoms, a later age of onset (over 25 years), and a good response to low doses of drugs are indicative of a better outcome. By contrast, the worst case scenario would be an insidious illness over several years in a teenager from a disrupted family who shows possible brain damage or additional learning difficulties.
What is clear is that the residual population of the old asylums—incontinent, mute, and utterly dependent—is a thing of the past. However, a younger group of constantly relapsing patients (“revolving-door patients”) shows the limitations of community support. Failure to comply with medication is often a key factor, and research into improving compliance in the community is showing some success.
Schizophrenia remains a diagnostic, clinical, and rehabilitative challenge
The development of local guidelines and supportive general practices or psychiatric liaison clinics are both educational and effective. Stigma and media hype of isolated assaults (such as the Christopher Clunis affair) tend to mask the good stability and personal functioning of the great majority of patients. Human resources in the form of community psychiatric nurses, social workers, occupational therapists, and care workers are often underestimated as well as underfunded.
National Schizophrenia Fellowship (NSF), 28 Castle Street, Kingston upon Thames, Surrey, KT1 1SS
Telephone (0181) 547 3937, Advice Service (0181) 974 6814
Publishes a useful leaflet for patients and families: What is schizophrenia?
Schizophrenia: A National Emergency (SANE), 199-205 Old Marylebone Road, London NW1 5QP
Saneline (0171) 724 8000 and 0345 67 8000
The Manic Depressive Fellowship has active local groups in many areas
MIND (National Association for Mental Health), Granta House, 15-17 Broadway, Stratford, London E15 4BQ
Info-Line (0181) 522 1728 and 0345 660 163
Excellent information is obtainable from voluntary groups such as the National Schizophrenia Fellowship or the Hearing Voices Network. New drug and psychological treatments, as well as research insights into the differing syndromes and symptoms, give hope for the future.
Mania and other psychoses
Psychotic symptoms, often indistinguishable from those seen in schizophrenia, occur in manic-depressive illness. Mania typically presents with hyperactivity, an elevated or excessively irritable mood, sleep loss, pressure of speech, and a tendency to jump from topic to topic (flight of ideas). The latter may mimic forms of thought disorder, while grandiose beliefs (often delusional) may generate excess spending or a chaotic personal lifestyle. Hypomania is the term applied to a less severe form without psychotic features.
Modern classification systems recognise the existence of acute and transient psychotic disorders, often occurring in association with stress, which may resolve spontaneously in a few days or weeks. On the other hand, persistent delusional disorder is characterised by circumscribed delusional beliefs of long standing in the absence of other psychotic features or of intellectual deterioration. Schizophrenic or manic symptoms may arise in a range of infective disorders (such as malaria and HIV infection), metabolic disorders (such as hypothyroidism), and idiopathic cerebral disorders.
Barrowclough C, Tarrier N. Families of schizophrenic patients: cognitive behavioural intervention. London: Chapman and Hall, 1992
Burns T. Early detection of psychosis in primary care: initial treatment and crisis management. In: Kendrick T, Tylee A, Freeling P, eds. The prevention of mental illness in primary care. Cambridge: Cambridge University Press, 1996:246-62
Davies TW. Psychosocial factors and relapse of schizophrenia BMJ 1994;309:353-4.
Long-term management of people with psychotic disorders in the community. Drug Ther Bull 1994;32:73-7
Pickar D. Prospects for pharmacotherapy of schizophrenia Lancet 1995;345:557-62
Tylee A. Guidelines for schizophrenia management. Hospital Update 1994:(supplement, Psychiatry Seminar):23
Wilkinson G, Kendrick T. A carer's guide to schizophrenia. London: Royal Society of Medicine Press, 1996
The artwork is by Melissa Husby and reproduced with permission of the Stock Illustration Source.
Trevor Turner is consultant psychiatrist, St Bartholomew's and the Homerton Hospitals, London.
The ABC of mental health is edited by Teifion Davies, senior lecturer in community psychiatry, United Medical and Dental Schools, St Thomas's Hospital, London, and honorary consultant psychiatrist, Lambeth Healthcare NHS Trust, and T K J Craig, professor of community psychiatry, United Medical and Dental Schools, St Thomas's Hospital.
Log in using your username and password
Log in through your institution
Sign up for a free trial